Patrick S. Ward
Molecular Biology · 2009–2020
A researcher in the Science corpus: 8 papers; trusts 6 researchers and is trusted by 9 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 111 citations into it; #6,172 of 17,773 by trust here, #1,948 by citations
- Cancer Research — 68 citations into it; #557 of 1,780 by trust here, #249 by citations
- Genetics — 38 citations into it; #4,929 of 6,854 by trust here, #360 by citations
- Neurology — 6 citations into it
Whom Patrick S. Ward trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- M. V. Vander Heiden
- David R. Wise
- Frank M. Sacks
- Ralph J. Deberardinis
- S. Mazurek
- Craig B. Thompson
- D. Hanahan
- Maria E. Figueroa
- Lewis C. Cantley
- Jung-whan Kim
Who trusts Patrick S. Ward overall
- Hao Wu
- Ralph J. Deberardinis
- Craig B. Thompson
- J. Cantor
- M. V. Vander Heiden
- Sophia Y. Lunt
- G. Semenza
- G. J. Yoshida
- Erika L. Pearce
- Yi Zhang
Papers from Patrick S. Ward's perspective
Ordered by how strongly the researchers Patrick S. Ward trusts endorse each paper. Same corpus, a different order for every researcher.
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (Nature)
- Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis (Proceedings of the National Academy of Sciences of the United States of America)
- The PyMOL Molecular Graphics System
- Analysis of the IDH1 codon 132 mutation in brain tumors (Acta Neuropathologica)
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth (Nature)
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme (Science)
- c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism (Nature)
- ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation (Science)
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (Science)
- ATP citrate lyase inhibition can suppress tumor cell growth. (Cancer Cell)
Their papers
- Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation (2010) — 2,704 citations
- IDH mutation impairs histone demethylation and results in a block to cell differentiation (2012) — 1,923 citations
- Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability (2011) — 984 citations
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype (2012) — 1,888 citations
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) — 3,098 citations
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (2009) — 4,048 citations
- MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations (2020) — 1,498 citations
- The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzymatic activity that converts α-ketoglutarate to 2-hydroxyglutarate (2010) — 1,965 citations